Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder

This study has been terminated.
(Slow subject recruitment.)
Information provided by (Responsible Party):
Gagan Joshi, MD, Massachusetts General Hospital Identifier:
First received: December 28, 2007
Last updated: November 13, 2012
Last verified: November 2012
Results First Received: July 28, 2011  
Study Type: Interventional
Study Design: Allocation: Non-Randomized;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Conditions: Pediatric Bipolar Disorder
Pediatric OCD
Intervention: Drug: fluoxetine

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
Fluoxetine No text entered.

Participant Flow:   Overall Study
Non-compliance                1 
Adverse Event                3 
Found ineligible                1 
Withdrawal by Subject                1 

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Fluoxetine No text entered.

Baseline Measures
Overall Participants Analyzed 
[Units: Participants]
[Units: Participants]
<=18 years   12 
Between 18 and 65 years   1 
>=65 years   0 
[Units: Years]
Mean (Standard Deviation)
 12.46  (3.91) 
[Units: Participants]
Female   4 
Male   9 
Region of Enrollment 
[Units: Participants]
United States   13 

  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS)   [ Time Frame: weekly ]

2.  Secondary:   Young Mania Rating Scale (YMRS)   [ Time Frame: weekly ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Gagan Joshi, MD
Organization: Massachusetts General Hospital
phone: 617-503-1084

Responsible Party: Gagan Joshi, MD, Massachusetts General Hospital Identifier: NCT00592852     History of Changes
Other Study ID Numbers: 2005-P-001840
Study First Received: December 28, 2007
Results First Received: July 28, 2011
Last Updated: November 13, 2012